You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 00998-0408


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00998-0408

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 0998-0408: Isopto Tears

Introduction

Isopto Tears, identified by the National Drug Code (NDC) 0998-0408, is an over-the-counter (OTC) ophthalmic solution manufactured and distributed by Alcon Laboratories, Inc. This product is primarily used to treat dry eyes and other ocular irritations. Here, we will delve into the market analysis and price projections for Isopto Tears.

Market Overview of OTC Ophthalmic Solutions

The market for OTC ophthalmic solutions is part of the broader pharmaceutical industry, which is experiencing significant trends and changes. The US pharmaceutical market, for instance, is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[4].

Product Details: Isopto Tears

Isopto Tears is labeled and distributed by Alcon Laboratories, Inc., and its primary component is Hypromellose 2910, with an active ingredient strength of 5 mg/mL. It has been on the market since September 30, 1990[1].

Market Trends in the Pharmaceutical Industry

Several trends are shaping the pharmaceutical industry, including a focus on prevention, personalization, prediction, and point of care. These trends are driven by advancements in technology, such as the increasing adoption of AI-based tools for drug discovery and development[3][4].

Pricing Dynamics in the Pharmaceutical Market

Pricing in the pharmaceutical market is complex and influenced by various factors, including production costs, regulatory approvals, and market demand. The median price increase for generic drugs was 19.9% in 2022, while brand name drugs saw a median increase of 13.4%[2].

Price Projections for Isopto Tears

Given the stable nature of OTC products and the lack of significant price volatility typically associated with generic or brand name drugs, price projections for Isopto Tears are likely to be relatively stable. Here are a few key points to consider:

Historical Pricing Stability

OTC products like Isopto Tears generally experience less price volatility compared to prescription drugs. This stability is due to their widespread availability and the competitive nature of the OTC market.

Market Demand

The demand for ophthalmic solutions is driven by the prevalence of dry eyes and other ocular conditions. As the population ages, the demand for these products is likely to increase, but this may not significantly impact the price due to the competitive market.

Regulatory Environment

The regulatory environment for OTC drugs is less stringent than for prescription drugs, but changes in regulations or policies could affect pricing. However, given the long-standing presence of Isopto Tears in the market, significant regulatory changes are unlikely to drastically alter its pricing.

Competitive Landscape

The ophthalmic solution market is competitive, with several brands available. This competition helps maintain price stability as manufacturers strive to remain competitive.

Potential Price Increases

While significant price increases are unlikely for Isopto Tears, minor adjustments could occur due to inflation, changes in raw material costs, or shifts in market dynamics. However, these increases would likely be modest and in line with overall market trends.

Conclusion

Isopto Tears, with its long history and stable market presence, is expected to maintain relatively stable pricing. The broader pharmaceutical market trends, including the adoption of AI and increased focus on prevention and personalization, do not directly impact the pricing of OTC ophthalmic solutions like Isopto Tears.

Key Takeaways

  • Stable Market Presence: Isopto Tears has been on the market since 1990, indicating a stable product with minimal price volatility.
  • OTC Market Dynamics: The OTC market is competitive, which helps maintain price stability.
  • Regulatory Stability: The regulatory environment for OTC drugs is less likely to cause significant price changes.
  • Market Demand: Increasing demand due to an aging population may not significantly impact prices due to market competition.
  • Minor Price Adjustments: Potential minor price increases could occur due to inflation or changes in raw material costs.

FAQs

Q: What is the primary component of Isopto Tears?

A: The primary component of Isopto Tears is Hypromellose 2910[1].

Q: Who manufactures and distributes Isopto Tears?

A: Isopto Tears is manufactured and distributed by Alcon Laboratories, Inc.[1].

Q: What is the expected growth rate of the US pharmaceutical market?

A: The US pharmaceutical market is projected to grow at a CAGR of 5.36% from 2022 to 2030[4].

Q: What are the key trends shaping the future of the pharmaceutical industry?

A: Key trends include a focus on prevention, personalization, prediction, and point of care, driven by advancements in technology such as AI[3].

Q: How does the competitive landscape affect the pricing of Isopto Tears?

A: The competitive nature of the OTC ophthalmic solution market helps maintain price stability for products like Isopto Tears.

Sources

  1. FDA.report: NDC 0998-0408 Ophthalmic Solution Isopto Tears.
  2. Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations.
  3. PwC: Pharma industry trends: Meeting the moment.
  4. GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030.
  5. FDA: National Drug Code Database Background Information.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.